ArticleOncotarget2017

Mitochondrial "power" drives tamoxifen resistance: NQO1 and GCLC are new therapeutic targets in breast cancer.

Marco Fiorillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.